
|Articles|March 28, 2008
FDA studying link between Singulair and suicides
The FDA is undertaking a study of Merck?s Singulair to see if it is associated with a higher rate of suicide.
Advertisement
The Food & Drug Administration has sent an
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
2025-2026 COVID-19 Vaccines Cut Risk of Hospitalization Nearly in Half
2
FDA Panel to Evaluate 7 Popular Peptides for Compounding Substances List
3
FDA Accepts Sandoz Applications for Generic Tirzepatide
4
FDA Approves First Dual Inhibitor Treatment for IgA Nephropathy
5































